A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401)-Reference-Cited by-同舟云学术

A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401)

Published:2021-01 Issue:1 Volume:10 Page:252-260
ISSN:2218-6751
Container-title:Translational Lung Cancer Research
language:
Short-container-title:Transl Lung Cancer Res

Author:

Okajima Masaaki,Miura Satoru,Watanabe Satoshi,Tanaka Hiroshi,Ito Kazuhiko,Ishida Takashi,Makino Masato,Iwashima Akira,Matsumoto Naoya,Sato Kazuhiro,Ichikawa Kosuke,Abe Tetsuya,Yoshizawa Hirohisa,Kikuchi Toshiaki

Publisher

AME Publishing Company

Subject

Oncology

Link

https://tlcr.amegroups.com/article/download/47019/pdf

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the risk of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors with cultured intestinal stem cells originated from crypts in humans and monkeys;Toxicology in Vitro;2023-12

2. Effects of polymorphisms in pregnane X receptor and ABC transporters on afatinib in Japanese patients with non-small cell lung cancer: pharmacogenomic–pharmacokinetic and exposure–response analysis;Cancer Chemotherapy and Pharmacology;2023-07-27

3. Elucidation of the inhibitory potential of flavonoids against PKP1 protein in non-small cell lung cancer;Cellular and Molecular Biology;2022-11-30

4. Titanium(IV) immobilized affinity chromatography facilitated phosphoproteomics analysis of salivary extracellular vesicles for lung cancer;Analytical and Bioanalytical Chemistry;2022-03-19

5. Tumor-Specificity, Neurotoxicity, and Possible Involvement of the Nuclear Receptor Response Pathway of 4,6,8-Trimethyl Azulene Amide Derivatives;International Journal of Molecular Sciences;2022-02-26